Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Large-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40).
Yokoyama H, Oishi M, Takamura H, Yamasaki K, Shirabe SI, Uchida D, Sugimoto H, Kurihara Y, Araki SI, Maegawa H. Yokoyama H, et al. Among authors: shirabe si. BMJ Open Diabetes Res Care. 2016 Oct 3;4(1):e000294. doi: 10.1136/bmjdrc-2016-000294. eCollection 2016. BMJ Open Diabetes Res Care. 2016. PMID: 27752329 Free PMC article.
Declining trends of diabetic nephropathy, retinopathy and neuropathy with improving diabetes care indicators in Japanese patients with type 2 and type 1 diabetes (JDDM 46).
Yokoyama H, Araki SI, Kawai K, Yamazaki K, Tomonaga O, Shirabe SI, Maegawa H. Yokoyama H, et al. Among authors: shirabe si. BMJ Open Diabetes Res Care. 2018 May 29;6(1):e000521. doi: 10.1136/bmjdrc-2018-000521. eCollection 2018. BMJ Open Diabetes Res Care. 2018. PMID: 29892340 Free PMC article.
The Prognosis of Patients With Type 2 Diabetes and Nonalbuminuric Diabetic Kidney Disease Is Not Always Poor: Implication of the Effects of Coexisting Macrovascular Complications (JDDM 54).
Yokoyama H, Araki SI, Kawai K, Yamazaki K, Shirabe SI, Sugimoto H, Minami M, Miyazawa I, Maegawa H; JDDM Study Group. Yokoyama H, et al. Among authors: shirabe si. Diabetes Care. 2020 May;43(5):1102-1110. doi: 10.2337/dc19-2049. Epub 2020 Mar 6. Diabetes Care. 2020. PMID: 32144168
Trends in glycemic control in patients with insulin therapy compared with non-insulin or no drugs in type 2 diabetes in Japan: a long-term view of real-world treatment between 2002 and 2018 (JDDM 66).
Yokoyama H, Araki SI, Yamazaki K, Kawai K, Shirabe SI, Oishi M, Kanatsuka A, Yagi N, Kabata D, Shintani A, Maegawa H; JDDM study group. Yokoyama H, et al. Among authors: shirabe si. BMJ Open Diabetes Res Care. 2022 May;10(3):e002727. doi: 10.1136/bmjdrc-2021-002727. BMJ Open Diabetes Res Care. 2022. PMID: 35504696 Free PMC article.
Both glimepiride and high-dose metformin are important for sustained glucose lowering in Japanese type 2 diabetes patients on glimepiride-sitagliptin-metformin therapy: subanalysis of a single-center, open-label, randomized study.
Arai K, Maeda H, Shirabe S, Yamamoto R, Kumakura A, Yamauchi M, Hirao T, Hirao S, Hirao K. Arai K, et al. Diabetes Technol Ther. 2014 Jul;16(7):442-6. doi: 10.1089/dia.2013.0310. Epub 2014 Feb 14. Diabetes Technol Ther. 2014. PMID: 24528246 Clinical Trial.
20 results